📰 With Determination News

With Determination News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from With Determination. Real-time updates on events, politics, business and more.

Plusieurs Persona auront droit à leur bande-son sur vinyle, précommandes et détails

February 23, 2024

Bonne nouvelle pour les amoureux et amoureuses de la série Persona qui aiment également profiter de leur platine. Trois jeux de la saga auront [...]

Vinyle Rose Memories Of The School Maximum Entertainment France Shrine Visit Reaching Out Stars Deep Breath

Source: actugaming.net

Persona 3 Reload vinyl soundtrack coming via iam8bit

February 14, 2024

The Persona 3 Reload soundtrack is coming to 4xlp vinyl thanks to iam8bit, and pre-orders are open for the collection from February 15th.

Atlus Sound Team Memories Of The School Holographic Broken Glass Vinyl Reaching Out Stars Breath Deep Amazing Commodities

Source: godisageek.com

Groove along to some of Persona 3 Reload's new music

November 12, 2023

Previews for some of Persona 3 Reload's music, both old and new, has been released along with the full track list. Take a listen here!

Michael Murphy Azumi Takahashi Timothy Monbleau Yumi Kawamura Edition Of Persona Limited Edition

Source: destructoid.com

Janssen Presents Longer-Term Talquetamab Follow-Up Data Showing Overall Response Rates of More Than 70 Percent in Heavily Pretreated Patients with Multiple Myeloma

June 3, 2023

/PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson announced today updated results from the pivotal Phase 1/2 MonumenTAL-1 study of the...

United States Talquetamab Monotherapy Satu Glawe Bhagirathbhai Dholaria Christie Corbett Chris Heuck

Source: prnewswire.com

Janssen Presents Efficacy and Subgroup Analyses from MAIA Study Showing Long-Term Results of DARZALEX® (daratumumab)-based Regimen in Newly Diagnosed, Transplant-Ineligible Multiple Myeloma

December 12, 2022

/PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new analyses from the Phase 3 MAIA study of DARZALEX® (daratumumab)...

United States Goldschmidth Daratumumab Shaji Kumar Mark Wildgust Christie Corbett Global Medical Affairs

Source: prnewswire.com

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Janssen to Highlight Latest Scientific Advances in Hematologic Diseases at ASH 2022 with Clinical and Real-World Data Across Innovative Pipeline and Distinguished Portfolio

November 3, 2022

/PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson are committed to redefining treatment outcomes in the hematology setting and today...

United States Hemophagocytic Lymphohistiocytosis Obrian Kenney Tyrone Brewer Peter Lebowitz Caroline Pavis

Source: prnewswire.com

Final Analysis of Phase 2 GRIFFIN Study Presented for DARZALEX® (daratumumab)-based Investigational Quadruplet Regimen in Patients with Newly Diagnosed, Transplant-Eligible Multiple Myeloma

August 28, 2022

/PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the final results from the randomized Phase 2 GRIFFIN study...

United States Bortezomib Melphalan Douglasw Sborov Velcade Melphalan Velcade Bortezomib Melphalan Imran Khan

Source: prnewswire.com

Final Analysis of Phase 2 GRIFFIN Study Presented for DARZALEX® (daratumumab)-based Investigational Quadruplet Regimen in Patients with Newly Diagnosed, Transplant-Eligible Multiple Myeloma - Press Release

August 27, 2022

Data featured in plenary session at the 19th International Myeloma Society Annual Meeting LOS ANGELES, Aug. 27, 2022 /PRNewswire/ -- The Janssen Pharm

United States Bortezomib Melphalan Douglasw Sborov Velcade Melphalan Velcade Bortezomib Melphalan Imran Khan

Source: wiredprnews.com

Final Analysis of Phase 2 GRIFFIN Study Presented for DARZALEX® (daratumumab)-based Investigational Quadruplet Regimen in Patients with Newly Diagnosed, Transplant-Eligible Multiple Myeloma

August 27, 2022

/PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the final results from the randomized Phase 2 GRIFFIN study...

United States Bortezomib Melphalan Douglasw Sborov Velcade Melphalan Velcade Bortezomib Melphalan Imran Khan

Source: prnewswire.com